0001104659-21-020197.txt : 20210211
0001104659-21-020197.hdr.sgml : 20210211
20210211063724
ACCESSION NUMBER: 0001104659-21-020197
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210210
FILED AS OF DATE: 20210211
DATE AS OF CHANGE: 20210211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Beebe Katherine
CENTRAL INDEX KEY: 0001768867
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13341
FILM NUMBER: 21616597
MAIL ADDRESS:
STREET 1: 400 OYSTER POINT BLVD, SUITE 505
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TITAN PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000910267
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943171940
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 OYSTER POINT BLVD
STREET 2: SUITE 505
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6502444990
MAIL ADDRESS:
STREET 1: 400 OYSTER POINT BLVD
STREET 2: SUITE 505
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
tm216217-1_4.xml
OWNERSHIP DOCUMENT
X0306
4
2021-02-10
0
0000910267
TITAN PHARMACEUTICALS INC
TTNP
0001768867
Beebe Katherine
400 OYSTER POINT BLVD, SUITE 505
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
President and COO
Option to Purchase Common Stock
4.02
2021-02-10
4
A
0
150000
0
A
2031-02-10
Common Stock
150000
150000
D
The options vest as to 75,000 shares on August 10, 2021 with the balance to vest in equal monthly installments over the 18 months thereafter.
/S/ Kate Beebe Devarney
2021-02-10